@article{91235ba3417b41c7995f54d43f415586,
title = "Treating Acne in Obese and Morbidly Obese Patients With Tazarotene 0.045\% Lotion: Post Hoc Analysis of Pooled Phase 3 Data",
author = "Jonette Keri and Kircik, \{Leon H.\} and Lawrence Green and Glynis Ablon and Werschler, \{William Philip\} and Tanghetti, \{Emil A.\} and Draelos, \{Zoe D.\} and Eric Guenin",
note = "Funding Information: Jonette Keri has served on speaker{\textquoteright}s bureau for Vyne Therapeutics. Leon Kircik has acted as an investigator, advisor, speaker, and consultant for Ortho Dermatologics. Lawrence Green has served as investigator, consultant, or speaker for Almirall, Cassiopea, Galderma, Ortho Dermatologics, Sol Gel, Sun Pharma, and Vyne. Glynis Ablon has served as a consultant and advisory board member for Galderma, Sinclair, Thermi-Almirall, Erchonia, Sunetics, Nutrafol, and Lifes2Good. William Philip Werschler has served as an investigator for Ortho Dermatologics. Emil Tanghetti has served as speaker for Novartis, Ortho Dermatologics, Sun Pharma, Lilly, Galderma, AbbVie, and Dermira; served as a consultant/clinical studies for Hologic, Ortho Dermatologics, and Galderma; and is a stockholder for Accure. Zoe Draelos received funding from Ortho Dermatologics to conduct the research presented in this poster. Eric Guenin is an employee of Ortho Dermatologics and may hold stock and/or stock options in its parent company.",
year = "2022",
month = mar,
day = "4",
doi = "10.25251/skin.6.supp.12",
language = "English",
volume = "6",
pages = "s12",
journal = "SKIN: Journal of Cutaneous Medicine",
issn = "2574-1624",
publisher = "National Society for Cutaneous Medicine",
number = "2",
}